On January 10, 2019, the Board resolution of Imexpharm Corporation approved the following issues:
1. Approving the amount of Technology and Science Development Fund:
No.
Content
Ratio
Amount (VND)
1
Profit before tax
100.00%
192,769,437,732
2
Amount deducted for Technology and Science Development Fund
9.86%
19,000,000,000
2. Approving the credit line in 2019 at banks:
- Credit line (guarantee to bid, bid performance guarantee): VND100 billion;
- Credit line (LC): VND100 billion.